Drug Resistance Mechanisms in CSCs

Cancer stem cells (CSCs) are notoriously resistant to standard cancer therapies, making them a major contributor to treatment failure and relapse. This track delves into the specific mechanisms that allow CSCs to resist chemotherapy and radiation, including the overexpression of drug efflux pumps, enhanced DNA repair, and activation of survival pathways. Researchers explore strategies to overcome these resistance mechanisms by developing drugs that target CSC-specific survival pathways. By identifying and inhibiting the factors that protect CSCs from treatment, this research aims to improve the efficacy of existing cancer therapies and reduce the likelihood of disease recurrence.

    Related Conference of Drug Resistance Mechanisms in CSCs

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Drug Resistance Mechanisms in CSCs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in